Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.

× No keyword cloud information.

59 in total

1. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels.

Authors: P Basse; R B Herberman; M Hokland; R H Goldfarb
Journal: Cancer Immunol Immunother Date: 1992 Impact factor: 6.968

2. Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.

Authors: J T Safrit; B Bonavida
Journal: Cancer Immunol Immunother Date: 1992 Impact factor: 6.968

3. A delicate balance: tweaking IL-2 immunotherapy.

Authors:
Journal: Nat Med Date: 2012-02-06 Impact factor: 53.440

Review 4. What's the place of immunotherapy in malignant mesothelioma treatments?

Authors: Marc Grégoire
Journal: Cell Adh Migr Date: 2010-01-30 Impact factor: 3.405

5. Interleukin-3 and interleukin-4 each strongly inhibit the induction and function of human LAK cells.

Authors: G Gallagher; F Wilcox; F al-Azzawi
Journal: Clin Exp Immunol Date: 1988-11 Impact factor: 4.330

6. Differential effects of BCNU on T cell, macrophage, natural killer and lymphokine-activated killer cell activities in mice bearing a syngeneic tumor.

Authors: M Nagarkatti; P S Nagarkatti; A M Kaplan
Journal: Cancer Immunol Immunother Date: 1988 Impact factor: 6.968

7. Human interleukin-2 activated cytotoxic cells kill autologous glioma cells in vitro.

Authors: V Bosnes; H Hirschberg
Journal: J Neurooncol Date: 1988 Impact factor: 4.130

8. Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease.

Authors: P R Gibson; E van de Pol; W Pullman; W F Doe
Journal: Gut Date: 1988-08 Impact factor: 23.059

9. Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activity.

Authors: M Toledano; C Mathiot; J Michon; G Andreu; D Lando; M Brandely; W H Fridman
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

10. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes.

Authors: S Kurosawa; M Harada; G Matsuzaki; Y Shinomiya; H Terao; N Kobayashi; K Nomoto
Journal: Immunology Date: 1995-06 Impact factor: 7.397